Lista de obras - Carlo Chiesa - Dominio Público Uruguay

Absorbed dose and biologically effective dose in patients with high-risk non-Hodgkin's lymphoma treated with high-activity myeloablative 90Y-ibritumomab tiuxetan (Zevalin).

artículo científico publicado en 2009

Association between [ 18 F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observation

artículo científico publicado en 1998

Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray"

artículo científico publicado en 2007

Comparison of Empiric Versus Dosimetry-Guided Radioiodine Therapy: The Devil Is in the Details

artículo científico publicado en 2017

Dosimetry in myeloablative (90)Y-labeled ibritumomab tiuxetan therapy: possibility of increasing administered activity on the base of biological effective dose evaluation. Preliminary results.

artículo científico publicado en 2007

EANM Dosimetry Committee guidance document: good practice of clinical dosimetry reporting ⬇️

artículo científico publicado el 27 de agosto de 2010

EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds

artículo científico publicado en 2011

EANM procedure guideline for treatment of refractory metastatic bone pain

scientific article published on 01 October 2008

Emission of 23F and 24Ne in cluster radioactivity of 231Pa

artículo científico publicado en 1992

First observation of spontaneous fission and search for cluster decay ofTh232

artículo científico publicado en 1995

High-dose yttrium-90-ibritumomab tiuxetan with tandem stem-cell reinfusion: an outpatient preparative regimen for autologous hematopoietic cell transplantation.

artículo científico publicado en 2008

Impact of SPECT corrections on 3D-dosimetry for liver transarterial radioembolization using the patient relative calibration methodology

artículo científico publicado en 2016

Intrahepatic flow redistribution in patients treated with radioembolization

artículo científico publicado en 2014

Long-Term Results of Autologous Hematopoietic Stem-Cell Transplantation After High-Dose 90Y-Ibritumomab Tiuxetan for Patients With Poor-Risk Non-Hodgkin Lymphoma Not Eligible for High-Dose BEAM.

artículo científico publicado en 2013

MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT Applied for Dosimetry of Radiopharmaceutical Therapy

artículo científico publicado en 2015

Neon radioactivity of uranium isotopes

artículo científico publicado en 1991

Preequilibrium (p,n) reaction as a probe for the effective nucleon-nucleon interaction in multistep direct processes

artículo científico publicado en 1990

Pretreatment Dosimetry in HCC Radioembolization with (90)Y Glass Microspheres Cannot Be Invalidated with a Bare Visual Evaluation of (99m)Tc-MAA Uptake of Colorectal Metastases Treated with Resin Microspheres.

artículo científico publicado en 2014

Prospective dosimetry with 99mTc-MDP in metabolic radiotherapy of bone metastases with 153Sm-EDTMP.

artículo científico publicado en 2008

Radiation dose to technicians per nuclear medicine procedure: comparison between technetium-99m, gallium-67, and iodine-131 radiotracers and fluorine-18 fluorodeoxyglucose

scientific article published on 01 November 1997

Radiation dosimetry is a necessary ingredient for a perfectly mixed molecular radiotherapy cocktail

artículo científico publicado en 2012

Radioembolization of hepatic lesions from a radiobiology and dosimetric perspective

artículo científico publicado en 2014

Radioembolization of hepatocarcinoma with (90)Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology.

artículo científico

Radioembolization of hepatocarcinoma with 90Y glass microspheres: treatment optimization using the dose-toxicity relationship

scientific article published on 25 May 2020

Radioiodine Therapy of Differentiated Thyroid Cancer

Sentinel node in breast cancer procedural guidelines

scientific article published on 01 December 2007

The "reset button" revisited: why high activity 131I therapy of advanced differentiated thyroid cancer after dosimetry is advantageous for patients.

artículo científico publicado en 2017

The Contribution of Positron Emission Tomography (Pet) with 18F-Fluorodeoxyglucose (Fdg) in the Preoperative Detection of Axillary Metastases of Breast Cancer: The Experience of the National Cancer Institute of Milan ⬇️

artículo científico publicado el 1 de marzo de 1997

The Italian multicentre dosimetric study for lesion dosimetry in 223Ra therapy of bone metastases: Calibration protocol of gamma cameras and patient eligibility criteria

artículo científico publicado en 2016

The conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy

artículo científico publicado en 2017

The dosimetric importance of the number of 90Y microspheres in liver transarterial radioembolization (TARE)

The evidence base for the use of internal dosimetry in the clinical practice of molecular radiotherapy

artículo científico publicado en 2014

The low hepatic toxicity per Gray of 90Y glass microspheres is linked to their transport in the arterial tree favoring a nonuniform trapping as observed in posttherapy PET imaging.

artículo científico publicado en 2013

Treatment with tandem [90Y]DOTA-TATE and [177Lu]DOTA-TATE of neuroendocrine tumours refractory to conventional therapy

artículo científico publicado en 2014

Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: A phase 2 study

scholarly article by Vincenzo Mazzaferro et al published 22 March 2013 in Hepatology

Lista de obras de Carlo Chiesa

Absorbed dose and biologically effective dose in patients with high-risk non-Hodgkin's lymphoma treated with high-activity myeloablative 90Y-ibritumomab tiuxetan (Zevalin).

Association between [ 18 F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observation

Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray"

Comparison of Empiric Versus Dosimetry-Guided Radioiodine Therapy: The Devil Is in the Details

Dosimetry in myeloablative (90)Y-labeled ibritumomab tiuxetan therapy: possibility of increasing administered activity on the base of biological effective dose evaluation. Preliminary results.

EANM Dosimetry Committee guidance document: good practice of clinical dosimetry reporting ⬇️

EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds

EANM procedure guideline for treatment of refractory metastatic bone pain

Emission of 23F and 24Ne in cluster radioactivity of 231Pa

First observation of spontaneous fission and search for cluster decay ofTh232

High-dose yttrium-90-ibritumomab tiuxetan with tandem stem-cell reinfusion: an outpatient preparative regimen for autologous hematopoietic cell transplantation.

Impact of SPECT corrections on 3D-dosimetry for liver transarterial radioembolization using the patient relative calibration methodology

Intrahepatic flow redistribution in patients treated with radioembolization

Long-Term Results of Autologous Hematopoietic Stem-Cell Transplantation After High-Dose 90Y-Ibritumomab Tiuxetan for Patients With Poor-Risk Non-Hodgkin Lymphoma Not Eligible for High-Dose BEAM.

MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT Applied for Dosimetry of Radiopharmaceutical Therapy

Neon radioactivity of uranium isotopes

Preequilibrium (p,n) reaction as a probe for the effective nucleon-nucleon interaction in multistep direct processes

Pretreatment Dosimetry in HCC Radioembolization with (90)Y Glass Microspheres Cannot Be Invalidated with a Bare Visual Evaluation of (99m)Tc-MAA Uptake of Colorectal Metastases Treated with Resin Microspheres.

Prospective dosimetry with 99mTc-MDP in metabolic radiotherapy of bone metastases with 153Sm-EDTMP.

Radiation dose to technicians per nuclear medicine procedure: comparison between technetium-99m, gallium-67, and iodine-131 radiotracers and fluorine-18 fluorodeoxyglucose

Radiation dosimetry is a necessary ingredient for a perfectly mixed molecular radiotherapy cocktail

Radioembolization of hepatic lesions from a radiobiology and dosimetric perspective

Radioembolization of hepatocarcinoma with (90)Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology.

Radioembolization of hepatocarcinoma with 90Y glass microspheres: treatment optimization using the dose-toxicity relationship

Radioiodine Therapy of Differentiated Thyroid Cancer

Sentinel node in breast cancer procedural guidelines

The "reset button" revisited: why high activity 131I therapy of advanced differentiated thyroid cancer after dosimetry is advantageous for patients.

The Contribution of Positron Emission Tomography (Pet) with 18F-Fluorodeoxyglucose (Fdg) in the Preoperative Detection of Axillary Metastases of Breast Cancer: The Experience of the National Cancer Institute of Milan ⬇️

The Italian multicentre dosimetric study for lesion dosimetry in 223Ra therapy of bone metastases: Calibration protocol of gamma cameras and patient eligibility criteria

The conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy

The dosimetric importance of the number of 90Y microspheres in liver transarterial radioembolization (TARE)

The evidence base for the use of internal dosimetry in the clinical practice of molecular radiotherapy

The low hepatic toxicity per Gray of 90Y glass microspheres is linked to their transport in the arterial tree favoring a nonuniform trapping as observed in posttherapy PET imaging.

Treatment with tandem [90Y]DOTA-TATE and [177Lu]DOTA-TATE of neuroendocrine tumours refractory to conventional therapy

Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: A phase 2 study

[18F]FDG synthesis by Anatech RB-86 robotic system: Improvements and general considerations